Administration of Immunoglobulins in SARS-CoV-2-Positive Patient Is Associated With Fast Clinical and Radiological Healing: Case Report.

COVID 19 PENTAGLOBIN SARS-CoV2 case report immunoglobulin pneumonia

Journal

Frontiers in medicine
ISSN: 2296-858X
Titre abrégé: Front Med (Lausanne)
Pays: Switzerland
ID NLM: 101648047

Informations de publication

Date de publication:
2020
Historique:
received: 29 04 2020
accepted: 22 06 2020
entrez: 9 8 2020
pubmed: 9 8 2020
medline: 9 8 2020
Statut: epublish

Résumé

Polyclonal preparation of IgM as an adjuvant therapy has been reported as a relevant immunomodulant therapy in several infectious diseases, exhibiting, in most cases, improvement of the clinical course. No drug has demonstrated therapeutic efficacy for COVID-19. Immunomodulatory treatment with hydroxychloroquine and biologics as tocilizumab, in fact, has not proven to show satisfactory results in several reports. We therefore treated a selected patient with interstitial multifocal pneumonia, positive to COVID-19, with polyclonal preparation of immunoglobulins as an adjuvant therapy, obtaining in few days clinical remission and improvements in radiological findings. Based on this case report, we suggest that clinical trials are conducted to test the efficacy and safety of polyclonal immunoglobulins for adjunctive therapy of COVID-19.

Identifiants

pubmed: 32766266
doi: 10.3389/fmed.2020.00388
pmc: PMC7378528
doi:

Types de publication

Case Reports

Langues

eng

Pagination

388

Informations de copyright

Copyright © 2020 Carannante, Fiorentino, Corcione, Di Sarno, Spatarella, Maturo, Fragranza and Di Micco.

Références

Infect Dis (Lond). 2018 Mar;50(3):214-219
pubmed: 28988525
JAMA. 2020 Apr 6;:
pubmed: 32250385
Open Forum Infect Dis. 2020 Mar 21;7(3):ofaa102
pubmed: 32258207
Lancet Respir Med. 2020 Mar;8(3):e11-e12
pubmed: 32061335
JAMA. 2020 Feb 24;:
pubmed: 32091533
Ann Intensive Care. 2019 Dec 3;9(1):135
pubmed: 31797105
Lancet. 2020 Mar 28;395(10229):1033-1034
pubmed: 32192578
J Biol Regul Homeost Agents. 2020 Apr 07;34(2):339-343
pubmed: 32253888
J Endocrinol Invest. 2020 Jul;43(7):1035-1036
pubmed: 32300975
J Infect. 2020 Jul;81(1):e21-e23
pubmed: 32283143
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Clin Microbiol Infect. 2003 May;9(5):333-8
pubmed: 12848745

Auteurs

Novella Carannante (N)

Emergency Infectious Disease p.o. Cotugno-Monaldi, A.O. dei Colli, Naples, Italy.
UOC Medicina, Ospedale Fatebenefratelli di Naples, Naples, Italy.

Giuseppe Fiorentino (G)

Emergency Infectious Disease p.o. Cotugno-Monaldi, A.O. dei Colli, Naples, Italy.
UOC Medicina, Ospedale Fatebenefratelli di Naples, Naples, Italy.

Antonio Corcione (A)

Emergency Infectious Disease p.o. Cotugno-Monaldi, A.O. dei Colli, Naples, Italy.
UOC Medicina, Ospedale Fatebenefratelli di Naples, Naples, Italy.

Raffaele Di Sarno (R)

Emergency Infectious Disease p.o. Cotugno-Monaldi, A.O. dei Colli, Naples, Italy.
UOC Medicina, Ospedale Fatebenefratelli di Naples, Naples, Italy.

Micaela Spatarella (M)

Emergency Infectious Disease p.o. Cotugno-Monaldi, A.O. dei Colli, Naples, Italy.
UOC Medicina, Ospedale Fatebenefratelli di Naples, Naples, Italy.

Nicola Maturo (N)

Emergency Infectious Disease p.o. Cotugno-Monaldi, A.O. dei Colli, Naples, Italy.
UOC Medicina, Ospedale Fatebenefratelli di Naples, Naples, Italy.

Fiorentino Fragranza (F)

Emergency Infectious Disease p.o. Cotugno-Monaldi, A.O. dei Colli, Naples, Italy.
UOC Medicina, Ospedale Fatebenefratelli di Naples, Naples, Italy.

Pierpaolo Di Micco (P)

Emergency Infectious Disease p.o. Cotugno-Monaldi, A.O. dei Colli, Naples, Italy.
UOC Medicina, Ospedale Fatebenefratelli di Naples, Naples, Italy.

Classifications MeSH